International Biotechnology (LON:IBT) Announces Quarterly Earnings Results

International Biotechnology (LON:IBT) released its earnings results on Tuesday. The company reported GBX (4.83) earnings per share for the quarter, Digital Look Earnings reports. International Biotechnology had a negative return on equity of 0.45% and a negative net margin of 6.26%.The firm had revenue of GBX 24 million for the quarter.

International Biotechnology Stock Performance

LON IBT traded down GBX 18 during trading on Tuesday, reaching GBX 972. 19,538 shares of the company traded hands, compared to its average volume of 59,890. The stock’s 50 day moving average price is GBX 931.35 and its two-hundred day moving average price is GBX 928.16. The company has a market cap of £309.37 million, a price-to-earnings ratio of -295.44 and a beta of 0.49. International Biotechnology has a 1-year low of GBX 546 and a 1-year high of GBX 1,010.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.